InDex Pharmaceuticals Holding AB Share Price Nasdaq Stockholm
Equities
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- SEK | - |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 239M 2.56B 18.83B |
---|---|---|---|---|---|
Net income 2024 * | -259M -2.77B -20.39B | Net income 2025 * | -221M -2.37B -17.4B | EV / Sales 2024 * | - |
Net Debt 2024 * | 86.32M 925M 6.8B | Net Debt 2025 * | 306M 3.28B 24.08B | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.92
x | P/E ratio 2025 * |
-1.1
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 62.47% |
Managers | Title | Age | Since |
---|---|---|---|
Jenny Sundqvist
CEO | Chief Executive Officer | 53 | 31/12/22 |
Johan Gileus
DFI | Director of Finance/CFO | 59 | 30/04/17 |
Charlotte Admyre
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Uli Alf Hacksell
BRD | Director/Board Member | 74 | 31/12/15 |
Director/Board Member | 68 | 31/12/10 | |
Chairman | 72 | 31/12/10 |
1st Jan change | Capi. | |
---|---|---|
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |